Who would be the best partner for ACW?
Pfizer?
Sanofi?
Biogen?
As Dr K mentioned below:
While Actinogen’s programs remain at an early stage, the company is a potential takeover target. Last year, Abbvie, Takeda and Eli Lilly all executed pre-clinical Alzheimer’s deals.“Big pharma in the past has said ‘we like what you do, but bring us a signal that your hypothesis has some clinical substance’,” Dr Ketelbey says.Xanahes trial lead investigator, Prof Michael Woodward from Melbourne’s Austin Health, says that given the many past failures in the development of Alzheimer’s drugs, the Xanahes results “renewed hope for a treatment breakthrough for this devastating disease”.
please see link for more info:
https://unauthorised investment advice/health/dr-borehams-crucible-actinogen-on-the-mend-after-a-near-death-experience/
dyor
Partnerships with ACW?
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.004(11.4%) |
Mkt cap ! $84.08M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.0¢ | $501.2K | 16.01M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1647475 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 321203 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |